Skip Content
You are currently on the new version of our website. Access the old version .

Vaccines, Volume 13, Issue 3

2025 March - 127 articles

Cover Story: Bovine respiratory syncytial virus (BRSV) is a major pathogen in calves, responsible for severe respiratory outbreaks. Its high mutation rate leads to genetic diversity, potentially affecting vaccine efficacy. In this study, we identified strains from subgroups II and VIII circulating in Wallonia, Belgium, with subgroup VIII being documented for the first time in the country. Current vaccines are based on strains from subgroups II and III, raising questions about their effectiveness, particularly against subgroup VIII. The continuous evolution of BRSV highlights the need for sustained surveillance to guide vaccine strategies. Given its widespread distribution, monitoring viral diversity in other countries is crucial for effective disease control. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (127)

  • Article
  • Open Access
1,614 Views
14 Pages

Stakeholders Perspectives on the Introduction of an Additional Injectable Vaccine Under the Universal Immunization Programme in India

  • Pawan Kumar,
  • Rashmi Mehra,
  • Arindam Ray,
  • Amrita Kumari,
  • Kapil Singh,
  • Rhythm Hora,
  • Amanjot Kaur,
  • Seema S. Koshal,
  • Syed F. Quadri and
  • Arup Deb Roy
  • + 2 authors

20 March 2025

Introduction: In 2023, India’s National Technical Advisory Group on Immunization (NTAGI) recommended the inclusion of typhoid conjugate vaccine (TCV) in the Universal Immunization Programme (UIP). However, introducing TCV, an additional injecta...

  • Article
  • Open Access
1 Citations
1,942 Views
13 Pages

20 March 2025

Background: Pre-existing adenovirus immunity restricts the utilization of adenovirus-vectored vaccines. The current study aims to conduct a pooled analysis of eight clinical trials to evaluate the influence of pre-existing Ad5 neutralizing antibodies...

  • Systematic Review
  • Open Access
2,567 Views
15 Pages

Comparative Analysis of Health Economic Evaluations for Different Influenza Vaccines and Vaccination Strategies in China: A Systematic Review

  • Fanxu Kong,
  • Li Cai,
  • Jiayi Zhang,
  • Huijie Zhu,
  • Zhibin Peng,
  • Jiandong Zheng,
  • Yaming Zheng and
  • Hai Fang

20 March 2025

Objective: This study systematically reviews health economic evaluations of influenza vaccines in China and synthesizes the evidence on different vaccine categories. Methods: We searched databases, including the China Hospital Knowledge Database, Wan...

  • Article
  • Open Access
1 Citations
2,056 Views
17 Pages

Application of Humanized MHC Transgenic Mice in the Screening of HLA–Restricted T Cell Epitopes for Influenza Vaccines

  • Yuwei Wei,
  • Keyu Sun,
  • Xuelian Han,
  • Yali Sun,
  • Jiejie Zhang,
  • Yuan Wang,
  • Qi Yin,
  • Tiantian Yang,
  • Kai Yuan and
  • Guangyu Zhao
  • + 1 author

20 March 2025

Background: Annual influenza epidemics pose a significant burden on the global healthcare system. The currently available vaccines mainly induce the production of neutralizing antibodies against hemagglutinin and neuraminidase, which are prone to ant...

  • Review
  • Open Access
4 Citations
4,721 Views
25 Pages

20 March 2025

CD169 is a sialic acid-binding immunoglobulin-like lectin (Siglec-1, sialoadhesin) that is expressed by subsets of tissue-resident macrophages and circulating monocytes. This receptor interacts with α2,3-linked Neu5Ac on glycoproteins as well a...

  • Article
  • Open Access
1,604 Views
13 Pages

Interplay Between Viral Shedding, Age, and Symptoms in Individual Infectivity of COVID-19 Breakthrough Infections in Households

  • Shuaibing Dong,
  • Ying Sun,
  • Shuyu Ni,
  • Yi Tian,
  • Zhaomin Feng,
  • Lei Jia,
  • Xiaoli Wang,
  • Daitao Zhang,
  • Quanyi Wang and
  • Peng Yang
  • + 1 author

19 March 2025

Background/Objectives: Understanding the factors influencing breakthrough infections following COVID-19 vaccination is critical for disease prevention, especially in households where transmission risks are high. Factors such as age, symptoms, living...

  • Article
  • Open Access
6 Citations
3,963 Views
16 Pages

Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults

  • Natalia Castillo Almeida,
  • Lalitha Parameswaran,
  • Elliot N. DeHaan,
  • Hayley Wyper,
  • Farah Rahman,
  • Qin Jiang,
  • Wen Li,
  • Michael Patton,
  • Maria Maddalena Lino and
  • Iona Munjal
  • + 11 authors

19 March 2025

Background/Objectives: Individuals with immunocompromising conditions are at high risk of developing severe respiratory syncytial virus (RSV) illness. This phase 3, single-arm study assessed the safety and immunogenicity of the bivalent RSV prefusion...

  • Article
  • Open Access
3 Citations
4,313 Views
25 Pages

An mRNA Vaccine for Herpes Zoster and Its Efficacy Evaluation in Naïve/Primed Murine Models

  • Linglei Jiang,
  • Wenshuo Zhou,
  • Fei Liu,
  • Wenhui Li,
  • Yan Xu,
  • Zhenwei Liang,
  • Man Cao,
  • Li Hou,
  • Pengxuan Liu and
  • Yuntao Zhang
  • + 8 authors

19 March 2025

Background/Objectives: An overwhelming burden to clinics, herpes zoster (HZ), or shingles, is a painful disease that occurs frequently among aged individuals with a varicella-zoster virus (VZV) infection history. The cause of shingles is the reactiva...

  • Article
  • Open Access
1 Citations
1,924 Views
10 Pages

Cell-Based Relative Potency of a Respiratory Syncytial Virus mRNA Vaccine Correlates with In Vivo Immunogenicity

  • Katrina Feller,
  • Hesham Nawar,
  • Liping Song,
  • Amanda Abrams,
  • Liang Shang,
  • Ashley Gruber,
  • Tatyana Yun and
  • Hualin Helen Li

19 March 2025

Background/Objectives: Potency is a critical quality attribute for vaccine development as well as clinical drug product (DP) lot release and stability testing. Animal studies have the potential to offer conclusive insights about the potency of vaccin...

  • Article
  • Open Access
1 Citations
1,567 Views
19 Pages

Determinants of Ukrainian Mothers’ Intentions to Vaccinate Their Children in Poland: A Cross-Sectional Study

  • Katarzyna Lewtak,
  • Joanna Mazur,
  • Harriet Dwyer,
  • Agnieszka Sochoń-Latuszek,
  • Anastasiya Atif,
  • Tomasz Maciejewski and
  • Dorota Kleszczewska

19 March 2025

Background/Objectives: In 2022, the full-scale invasion in Ukraine forced over 6 million Ukrainians, primarily mothers and children, to seek safety outside of the country. This massive influx has posed a significant challenge to the Polish healthcare...

  • Article
  • Open Access
1 Citations
1,718 Views
13 Pages

Targeted Delivery of Personalized Cancer Vaccines Based on Antibody–Antigen Complexes

  • Yaling Zhang,
  • Lingling Yan,
  • He Sun,
  • Ziyi Zhang,
  • Fengyun Shen and
  • Lele Sun

19 March 2025

Background: Personalized cancer vaccines based on tumor neoantigens show great potential in cancer immunotherapy due to their high safety and specificity. However, it is inherently difficult to realize the efficiently targeted delivery of personalize...

  • Article
  • Open Access
3,747 Views
16 Pages

Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in Spain

  • Alberto Perez-Rubio,
  • Roberto Flores,
  • Jesus Ruiz Aragon,
  • Javier Sanchez,
  • Sergio Marquez-Peláez,
  • Piedad Alvarez,
  • Andres Osorio Muriel and
  • Joaquin Mould-Quevedo

19 March 2025

Background: The prevalence of chronic conditions that increase the risk of influenza complications is high among individuals aged ≥50 years, and evidence suggests age-related changes in immune responses to vaccines begin to decline at this age. Pe...

  • Article
  • Open Access
2 Citations
2,317 Views
19 Pages

Beyond Vaccination: Exploring Young Adults’ Awareness, Knowledge, and Attitudes Related to Sexually Transmitted Infections in Romania

  • Alexandra-Ioana Roșioară,
  • Bogdana Adriana Năsui,
  • Nina Ciuciuc,
  • Dana Manuela Sîrbu,
  • Daniela Curșeu,
  • Romulus Florian Oprica,
  • Codruța Alina Popescu,
  • Rodica Ana Ungur,
  • Tamara Cheșcheș and
  • Monica Popa

18 March 2025

Background and Objectives: Romania has the highest rate of cervical cancer in Europe. The aim of this study is to measure the level of sexual health knowledge among participants and determine the extent to which factors such as age, gender, education...

  • Review
  • Open Access
2 Citations
1,876 Views
18 Pages

The Use of Residual Blood Specimens in Seroprevalence Studies for Vaccine-Preventable Diseases: A Scoping Review

  • Monica Pilewskie,
  • Christine Prosperi,
  • Abigail Bernasconi,
  • Ignacio Esteban,
  • Lori Niehaus,
  • Connor Ross,
  • Andrea C. Carcelen,
  • William J. Moss and
  • Amy K. Winter

18 March 2025

Background: Residual blood specimens offer a cost- and time-efficient alternative for conducting serological surveys. However, their use is often criticized due to potential issues with the representativeness of the target population and/or limited a...

  • Brief Report
  • Open Access
1 Citations
1,893 Views
10 Pages

Four-Color Pseudovirus-Based Neutralization Assay: A Rapid Method for Evaluating Neutralizing Antibodies Against Quadrivalent Hand, Foot, and Mouth Disease Vaccine

  • Fan Gao,
  • Lingjie Xu,
  • Qian Wang,
  • Gang Wang,
  • Mingchen Liu,
  • Lu Li,
  • Qian He,
  • Xuanxuan Zhang,
  • Ying Wang and
  • Xing Wu
  • + 4 authors

18 March 2025

Background/Objectives: Enterovirus 71 (EV71) and coxsackieviruses A16 (CA16), A10 (CA10), and A6 (CA6) are the primary pathogens that cause hand, foot, and mouth disease (HFMD). Currently, many manufacturers are developing bivalent, trivalent, and te...

  • Article
  • Open Access
1 Citations
2,407 Views
18 Pages

Impact of the Implementation of a Bovine Viral Diarrhea Virus Targeted Vaccine in Dairy Farms: Longitudinal Analysis

  • Demian Bellido,
  • Diego Wenz,
  • Martin Schang,
  • Facundo Tibaldo Rubiolo,
  • Pablo Mangioni,
  • Emanuel Gumina,
  • Andrés Wigdorovitz and
  • Viviana Parreño

17 March 2025

Objective: This study evaluated the effect of a novel subunit-targeted vaccine against BVDV in six dairy farms in Argentina. Methods: Reproductive, health, and production parameters—including conception and abortion rates, open days, calves bor...

  • Article
  • Open Access
4 Citations
1,993 Views
17 Pages

Antigen-Dependent Adjuvanticity of Poly(lactic-co-glycolic acid)-polyethylene Glycol 25% Nanoparticles for Enhanced Vaccine Efficacy

  • Minxuan Cui,
  • Jiayue Xi,
  • Zhuoyue Shi,
  • Yupu Zhu,
  • Zhengjun Ma,
  • Muqiong Li,
  • Qian Yang,
  • Chaojun Song and
  • Li Fan

16 March 2025

Background: A key component in modern vaccine development is the adjuvant, which enhances and/or modulates the antigen-specific immune response. In recent years, nanoparticle (NP)-based adjuvants have attracted much research attention owing to their...

  • Article
  • Open Access
4 Citations
2,670 Views
23 Pages

The Sm14+GLA-SE Recombinant Vaccine Against Schistosoma mansoni and S. haematobium in Adults and School Children: Phase II Clinical Trials in West Africa

  • Amadou Tidjani Ly,
  • Doudou Diop,
  • Modou Diop,
  • Anne-Marie Schacht,
  • Abdoulaye Mbengue,
  • Rokhaya Diagne,
  • Marieme Guisse,
  • Jean-Pierre Dompnier,
  • Carolina Messias and
  • Miriam Tendler
  • + 12 authors

16 March 2025

Background/Objectives: Following previous successful Phase I clinical trials conducted in men and women in a non-endemic area for schistosomiasis in Brazil, the Sm14 vaccine was evaluated in an endemic region in Senegal. We report successful clinical...

  • Article
  • Open Access
2 Citations
3,393 Views
13 Pages

Stabilizing Prefusion SARS-CoV-2 Spike by Destabilizing the Postfusion Conformation

  • Debajyoti Chakraborty,
  • Randhir Singh,
  • Raju S. Rajmani,
  • Sahil Kumar,
  • Rajesh P. Ringe and
  • Raghavan Varadarajan

14 March 2025

Background/Objectives: As with many viral fusion proteins, the native conformation of SARS-CoV-2 Spike is metastable. Most COVID-19 vaccines utilize a stabilized Spike (Spike-2P) containing two proline substitutions, and subsequently, a further stabi...

  • Article
  • Open Access
4 Citations
2,918 Views
20 Pages

Anti-Tumor Efficacy of a Mesothelin-Based Nanovaccine in a KPC Orthotopic Mouse Model of Pancreatic Cancer

  • Daniele P. Ferrari,
  • Özmen Çobanoglu,
  • Sana Sayedipour,
  • Omar Luna,
  • Sonia A. M. Ferkel,
  • David Agorku,
  • Yomkippur Perez,
  • Luis J. Cruz,
  • Fernando Albericio and
  • Fernanda Ramos-Gomes
  • + 3 authors

14 March 2025

Background/Objectives: Immunotherapy has shown promising results in some cancers, but its efficacy remains limited in pancreatic ductal adenocarcinoma (PDAC). Vaccines in nanoparticle form (nanovaccines) can incorporate immunostimulating components t...

  • Article
  • Open Access
1,385 Views
15 Pages

Effect of Anti-Programmed Cell Death-1 Antibody on Middle Ear Mucosal Immune Response to Intranasal Administration of Haemophilus influenzae Outer Membrane Protein

  • Kazuhiro Yoshinaga,
  • Takashi Hirano,
  • Shingo Umemoto,
  • Yoshinori Kadowaki,
  • Takayuki Matsunaga and
  • Masashi Suzuki

13 March 2025

Background/Objectives: Acute otitis media is a common pediatric infection caused primarily by nontypeable Haemophilus influenzae. With rising antibiotic resistance, vaccines are essential for combating this public health issue. Although the PD-1/PD-L...

  • Article
  • Open Access
1 Citations
2,011 Views
21 Pages

Robust COVID-19 Vaccine Responses Despite Filarial Co-Infection: Insights from a Lymphatic Filariasis Cohort in Ghana

  • Julia Meyer,
  • Jennifer Nadal,
  • Linda Batsa Debrah,
  • Alexander Yaw Debrah,
  • Jubin Osei-Mensah,
  • Derrick Adu Mensah,
  • Patricia Jebett Korir,
  • Janina M. Kuehlwein,
  • Ute Klarmann-Schulz and
  • Tomabu Adjobimey
  • + 1 author

13 March 2025

Background/Objectives: Although the COVID-19 pandemic has largely concluded, the varied trajectories it has followed in different regions of the world remain incompletely understood. Intensive research is needed to fully grasp its course and the impl...

  • Article
  • Open Access
1 Citations
1,406 Views
27 Pages

13 March 2025

Background/Objectives: Commercial poultry flocks undergo Salmonella vaccinations to manage salmonellosis outbreaks. Due to reports of severe injection site reactions to Salmonella bacterins, assessment of local inflammatory responses is necessary. Th...

  • Article
  • Open Access
3,027 Views
11 Pages

13 March 2025

Background/Objectives: Long-term studies on the immune response following multiple doses of SARS-CoV-2 mRNA vaccines remain limited. Methods: Secondary analyses of data from a cohort of non-immunocompromised subjects who received two doses of BNT162b...

  • Review
  • Open Access
5 Citations
1,733 Views
13 Pages

Vaccination Strategies: Mixing Paths Versus Matching Tracks

  • Achilleas Livieratos,
  • Charalambos Gogos,
  • Iason Thomas and
  • Karolina Akinosoglou

13 March 2025

Vaccination strategies play a pivotal role in achieving broad and robust immune protection. With the advent of new technologies and challenges posed by emerging infectious diseases such as SARS-CoV-2, evaluating the efficacy of homologous (matching t...

  • Article
  • Open Access
1 Citations
5,229 Views
14 Pages

The Effectiveness of Four Quadrivalent, Inactivated Influenza Vaccines Administered Alone or in Combination with Pneumococcal and/or SARS-CoV-2 Vaccines: A Population-Wide Cohort Study

  • Cecilia Acuti Martellucci,
  • Annalisa Rosso,
  • Enrico Zauli,
  • Alessandro Bianconi,
  • Matteo Fiore,
  • Graziella Soldato,
  • Patrizia Marani Toro,
  • Marco De Benedictis,
  • Graziano Di Marco and
  • Lamberto Manzoli
  • + 3 authors

13 March 2025

Background: Several influenza vaccine formulations are available, including adjuvanted, high-dose, trivalent, and quadrivalent vaccines, and direct, comparative evidence on the relative effectiveness is limited. Real-life data on the potential impact...

  • Perspective
  • Open Access
4 Citations
1,936 Views
12 Pages

The Mpox Response Among Key Populations at High Risk of or Living with HIV in Rwanda: Leveraging the Successful National HIV Control Program for More Impactful Interventions

  • Gallican Rwibasira,
  • Tafadzwa Dzinamarira,
  • Jean Claude Semuto Ngabonziza,
  • Albert Tuyishime,
  • Ayman Ahmed and
  • Claude Mambo Muvunyi

13 March 2025

Mpox, an emerging zoonotic infectious disease, presents a significant public health threat, especially among high-risk groups like female sex workers and men who have sex with men. This commentary reviews and summarizes Rwanda’s response to mpo...

  • Systematic Review
  • Open Access
6 Citations
3,127 Views
21 Pages

Intestinal Microbiota and Vaccinations: A Systematic Review of the Literature

  • Francesco Loddo,
  • Pasqualina Laganà,
  • Caterina Elisabetta Rizzo,
  • Serena Maria Calderone,
  • Bruno Romeo,
  • Roberto Venuto,
  • Daniele Maisano,
  • Francesco Fedele,
  • Raffaele Squeri and
  • Cristina Genovese
  • + 4 authors

12 March 2025

Background: Vaccination constitutes a low-cost, safe, and efficient public health measure that can help prevent the spread of infectious diseases and benefit the community. The fact that vaccination effectiveness varies among populations, and that th...

  • Article
  • Open Access
1 Citations
1,651 Views
11 Pages

Bacillus Calmette–Guérin Vaccination Promotes Efficient and Comprehensive Immune Modulation in Guinea Pig Models

  • In-Ohk Ouh,
  • Min Jung Kim,
  • Kwangwook Kim,
  • Heeji Lim,
  • Ye Jin Yang,
  • Ji Woong Heo,
  • Han Nim Choi,
  • Hun Hwan Kim,
  • Hu-Jang Lee and
  • Kwang Il Park
  • + 4 authors

12 March 2025

Background/Objectives: Tuberculosis (TB), caused by Mycobacterium tuberculosis H37Rv (M. tuberculosis), primarily affects the lungs. The Bacillus Calmette–Guérin (BCG) vaccine is the only available TB vaccine. Guinea pigs serve as a...

  • Review
  • Open Access
6 Citations
6,992 Views
18 Pages

Progress on Respiratory Syncytial Virus Vaccine Development and Evaluation Methods

  • Lie Deng,
  • Hongjie Cao,
  • Guichang Li,
  • Kaiwen Zhou,
  • Zihan Fu,
  • Jiaying Zhong,
  • Zhongfang Wang and
  • Xiaoyun Yang

12 March 2025

Respiratory syncytial virus (RSV) remains a significant global health threat, especially to infants, the elderly, and immunocompromised individuals. This review comprehensively explores the progress in RSV vaccine development, the immune evaluation m...

  • Article
  • Open Access
6 Citations
2,856 Views
16 Pages

Protection Against Pneumonia Induced by Vaccination with Fimbriae Subunits from Klebsiella pneumoniae

  • Lucas Assoni,
  • Isabelle Ciaparin,
  • Monalisa Martins Trentini,
  • Juliana Baboghlian,
  • Gabriel Rodrigo,
  • Brenda Vieira Ferreira,
  • José Aires Pereira,
  • Carlos Martinez,
  • Lucio Ferraz and
  • Michelle Darrieux
  • + 4 authors

11 March 2025

Background: Klebsiella pneumoniae infections pose a great burden worldwide, causing high morbidity and mortality, which are worsened by the increase in multidrug-resistant strains. New therapeutic/prophylactic strategies are urgently needed to overco...

  • Article
  • Open Access
1 Citations
2,197 Views
16 Pages

11 March 2025

Background: This paper investigates the long-term effects of the measles, mumps, and rubella (MMR) vaccine on healthcare, education, and economic outcomes using a novel dataset from the Copenhagen School Health Records Register. Methods: To address p...

  • Conference Report
  • Open Access
2 Citations
1,844 Views
9 Pages

The 2024 Annual Meeting of the Essential Programmes on Immunization Managers in Central Africa: A Peer Learning Platform

  • Franck Mboussou,
  • Audry Mulumba,
  • Celestin Traore,
  • Florence Conteh-Nordman,
  • Shalom Tchokfe Ndoula,
  • Antoinette Demian Mbailamen,
  • Jean Claude Bizimana,
  • Christian Akani,
  • Yolande Vuo-Masembe and
  • Benido Impouma
  • + 7 authors

11 March 2025

Background: Since 1974, Essential Programme on Immunisation managers from ten Central African countries meet yearly with partners to review progress made and share experiences and lessons learned from the implementation of immunization programmes. Th...

  • Systematic Review
  • Open Access
1 Citations
3,587 Views
27 Pages

11 March 2025

Background/Objectives: Human papillomavirus (HPV) is a predominant cause of cervical cancer globally in women. HPV-related cancers in men are also on the rise. Immunization against HPV infection is a highly effective preventative against these cancer...

  • Article
  • Open Access
1,293 Views
13 Pages

11 March 2025

Background/Objectives. Bovine botulism, although relatively rare, presents significant economic losses due to high mortality rates and restrictions on livestock product trade. Vaccination remains the most effective strategy for preventing botulism-re...

  • Article
  • Open Access
1,961 Views
11 Pages

Phylogenetic Analysis of Bovine Respiratory Syncytial Virus (BRSV) Subgroups in Wallonia Region of Belgium in Relation to Current Vaccination Strategies

  • Anneliese Demil,
  • Mickaël Dourcy,
  • Mutien-Marie Garigliany,
  • Dominique Cassart,
  • Fabien Grégoire,
  • Julien Evrard,
  • Daniel Desmecht,
  • Calixte Bayrou and
  • Hani Boshra

11 March 2025

Background: Bovine respiratory syncytial virus (BRSV) is a major pathogen of the bovine respiratory disease complex and causes regular severe winter outbreaks of respiratory disease in cattle. It is therefore responsible for important economic losses...

  • Viewpoint
  • Open Access
2 Citations
2,819 Views
10 Pages

Human Papilloma Virus Vaccination as a Strategy to Eliminate Cervical Cancer: Challenges and Opportunities

  • Maria L. Avila-Aguero,
  • Sebastian Ospina-Henao,
  • Helena Brenes-Chacon,
  • Carlos Espinal-Tejada,
  • Ruby Trejo-Varon and
  • Ana Morice

11 March 2025

In August 2020, the World Health Assembly approved the global strategy to eliminate cervical cancer, envisioning a world where it seizes to be a public health problem. The cervical cancer elimination initiative reinforces the commitment to fulfilling...

  • Article
  • Open Access
1,880 Views
20 Pages

Immunogenicity and Safety Profile of Two Adjuvanted-PD-L1-Based Vaccine Candidates in Mice, Rats, Rabbits, and Cynomolgus Monkeys

  • Camila Canaán-Haden,
  • Javier Sánchez-Ramírez,
  • Rafael Martínez-Castillo,
  • Mónica Bequet-Romero,
  • Pedro Puente-Pérez,
  • Isabel Gonzalez-Moya,
  • Yunier Rodríguez-Álvarez,
  • Marta Ayala-Ávila,
  • Jorge Castro-Velazco and
  • Yanelys Morera-Díaz
  • + 3 authors

11 March 2025

Background: The therapeutic blockade of the PD1/PD-L1 axis with monoclonal antibodies has led to a breakthrough in cancer treatment, as it plays a key role in the immune evasion of tumors. Nevertheless, treating patients with cancer with vaccines tha...

  • Article
  • Open Access
2,986 Views
12 Pages

10 March 2025

Background: Various factors influence the immunologic responses to HBV vaccines in adults, including unchangeable individual characteristics. Personalized vaccination regimens accounting for host factors can enhance immune efficiency, particularly fo...

  • Article
  • Open Access
1 Citations
2,778 Views
16 Pages

10 March 2025

Background/Objectives: Targeted delivery of antigens to dendritic cells (DCs) is an effective strategy for enhancing vaccine efficacy. Methods: In this study, dual-targeting fusion proteins (GRFT-VHH54 and GRFT-VHH74) were constructed by fusing Griff...

  • Article
  • Open Access
1,563 Views
16 Pages

Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV

  • Xiaoqing Guan,
  • Abhishek K. Verma,
  • Qian Liu,
  • Melissa Palacios,
  • Abby E. Odle,
  • Stanley Perlman and
  • Lanying Du

10 March 2025

Background. The pathogenic coronaviruses (CoVs) MERS-CoV and SARS-CoV-2, which are responsible for the MERS outbreak and the COVID-19 pandemic, respectively, continue to infect humans, with significant adverse outcomes. There is a continuing need to...

  • Review
  • Open Access
10 Citations
2,939 Views
22 Pages

Targeting PI3K Signaling to Overcome Tumor Immunosuppression: Synergistic Strategies to Enhance Cancer Vaccine Efficacy

  • Ran Cui,
  • Zhongxiang Luo,
  • Xialin Zhang,
  • Xinlin Yu,
  • Gang Yuan,
  • Xingming Li,
  • Fei Xie and
  • Ou Jiang

10 March 2025

Phosphoinositide 3-kinases (PI3Ks), members of the lipid kinase family, play a significant role in modulating immune cell functions, including activation, proliferation, and differentiation. Recent studies have identified the PI3K signaling pathway a...

  • Article
  • Open Access
2 Citations
2,080 Views
19 Pages

Prime-Boost Vaccination Based on Nanospheres and MVA Encoding the Nucleoprotein of Crimean-Congo Hemorrhagic Fever Virus Elicits Broad Immune Responses

  • Eva Calvo-Pinilla,
  • Sandra Moreno,
  • Natalia Barreiro-Piñeiro,
  • Juana M. Sánchez-Puig,
  • Rafael Blasco,
  • José Martínez-Costas,
  • Alejandro Brun and
  • Gema Lorenzo

10 March 2025

Background/Objectives: Crimean–Congo hemorrhagic fever virus (CCHFV) is an emerging, widely distributed zoonotic tick-borne pathogen. The virus causes severe disease in humans, and numerous wild and domestic animals act as reservoirs of it. Unf...

  • Article
  • Open Access
3 Citations
1,199 Views
14 Pages

10 March 2025

Background/Objectives: Equine herpesvirus type-1 (EHV-1) enters through the upper respiratory tract (URT) and causes respiratory disease, abortions, and myeloencephalopathy in equids. Pre-existing immunity at the viral entry site, especially mucosal...

  • Article
  • Open Access
1 Citations
1,922 Views
11 Pages

Incidence and Factors Associated with Self-Reported Skin Symptoms of Allergic Reactions to COVID-19 Vaccines

  • Karnsinee Thanborisutkul,
  • Prapasri Kulalert,
  • Kanthida Methaset,
  • Sira Nanthapisal,
  • Tibet Chunthatikul,
  • Nathamon Phangpanya,
  • Phenpraphatson Charoenying,
  • Worakamon Atsawutmangkru,
  • Suphatsara Srijaroen and
  • Orapan Poachanukoon
  • + 1 author

10 March 2025

Background: Few reports exist regarding the incidence and factors associated with allergic reactions to COVID-19 vaccines during post-marketing surveillance, especially for inactivated whole virus or viral vector vaccines. We aimed to determine the i...

  • Brief Report
  • Open Access
1,887 Views
10 Pages

10 March 2025

Background/Objectives: The current national vaccination program does not completely control the transmission of Bordetella pertussis in Croatia. This cross-sectional seroprevalence study aimed to measure the prevalence of IgG antibodies to pertussis...

  • Article
  • Open Access
2,544 Views
16 Pages

Meningococcal Vaccination in High-Risk Patients: A Systematic Approach to Evaluating Coverage and Patient Catch-Up Through Healthcare Databases

  • Rafael Ruiz-Montero,
  • Álvaro Serrano-Ortiz,
  • Mario Rivera-Izquierdo,
  • Piedad Galvache Murillo-Rico,
  • Ana Moñiz-Díez,
  • María Ángeles Onieva-García,
  • Eloy Girela-López and
  • Inmaculada Salcedo-Leal

8 March 2025

Background: Invasive meningococcal disease (IMD) can lead to severe and fatal outcomes. Vaccines against meningococcus (serogroups B, MenB; or ACWY, MenACWY) are recommended for patients at high risk of developing IMD. Our aim was to identify high-ri...

  • Article
  • Open Access
2,286 Views
11 Pages

7 March 2025

Background: This study aims to analyze the vaccination status and factors influencing delayed vaccination among toddlers born to hepatitis B surface antigen (HBsAg)-positive mothers. Methods: Data of HBsAg-positive mothers between 1 January 2021 and...

  • Review
  • Open Access
2 Citations
4,811 Views
44 Pages

Recent Progress in Developing Extracellular Vesicles as Nanovehicles to Deliver Carbohydrate-Based Therapeutics and Vaccines

  • Japigorn Puagsopa,
  • Niksa Tongviseskul,
  • Thapakorn Jaroentomeechai and
  • Bunyarit Meksiriporn

7 March 2025

Cell-derived, nanoscale extracellular vesicles (EVs) have emerged as promising tools in diagnostic, therapeutic, and vaccine applications. Their unique properties including the capability to encapsulate diverse molecular cargo as well as the versatil...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X